SOL-1 is a superiority study being conducted under a Special Protocol Agreement (SPA) with the US Food and Drug ...

EyePoint Pharmaceuticals has dosed the first patient in the LUCIA Phase 3 trial of Duravyu for wet AMD. The study evaluates ...

Prevent Blindness announces its fourth annual Geographic Atrophy Awareness Week, December 2 to 8, 2024. The organization ...

A team of Bascom Palmer Eye Institute and University of Miami researchers have received an award to fund the procurement, ...

Hyaluronic acid fillers are used for undereye volume correction, detailing aging effects on facial anatomy, common ...

In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers. In this series, experts ...

Lisa J. Faia, MD asks the panel about their concerns regarding the safety of newer agents for the broad array of retinal ...

In the third case, moderator Lisa J. Faia, MD presents her case of persistently active central retinal vein occlusion (CRVO), ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

About 33% of ocular tuberculosis patients may relapse within 2 years of achieving clinical inactivity, with a poor initial ...